Skip to main content

Peer Review reports

From: Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19

Original Submission
8 Apr 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
21 May 2021 Reviewed Reviewer Report
28 May 2021 Reviewed Reviewer Report
7 Jun 2021 Reviewed Reviewer Report - Magda H. Abdellatiif
19 Jul 2021 Author responded Author comments - Jack A. Tuszynski
Resubmission - Version 5
19 Jul 2021 Submitted Manuscript version 5
7 Aug 2021 Reviewed Reviewer Report
9 Aug 2021 Reviewed Reviewer Report
14 Aug 2021 Reviewed Reviewer Report - Magda H. Abdellatiif
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
29 Aug 2021 Editorially accepted
21 Oct 2021 Article published 10.1186/s40360-021-00519-5

You can find further information about peer review here.

Back to article page